These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 23266736

  • 1. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR, Ayoub NM, Abuasal BS, Kaddoumi A, Sylvester PW.
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
    Akl MR, Ayoub NM, Sylvester PW.
    Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
    Wali VB, Bachawal SV, Sylvester PW.
    Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
    [Abstract] [Full Text] [Related]

  • 4. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
    Tiwari RV, Parajuli P, Sylvester PW.
    Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV, Wali VB, Sylvester PW.
    BMC Cancer; 2010 Mar 08; 10():84. PubMed ID: 20211018
    [Abstract] [Full Text] [Related]

  • 7. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P, Tiwari RV, Sylvester PW.
    Biol Pharm Bull; 2015 Mar 08; 38(9):1352-60. PubMed ID: 26328490
    [Abstract] [Full Text] [Related]

  • 8. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.
    Tiwari RV, Parajuli P, Sylvester PW.
    Exp Biol Med (Maywood); 2014 Jan 08; 239(1):33-44. PubMed ID: 24231340
    [Abstract] [Full Text] [Related]

  • 9. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
    Shah SJ, Sylvester PW.
    Exp Biol Med (Maywood); 2005 Apr 08; 230(4):235-41. PubMed ID: 15792944
    [Abstract] [Full Text] [Related]

  • 10. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
    Wali VB, Sylvester PW.
    Lipids; 2007 Dec 08; 42(12):1113-23. PubMed ID: 17701065
    [Abstract] [Full Text] [Related]

  • 11. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
    Hsieh TC, Elangovan S, Wu JM.
    Anticancer Res; 2010 Jul 08; 30(7):2869-74. PubMed ID: 20683025
    [Abstract] [Full Text] [Related]

  • 12. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Jul 08; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA, Shanmugam MK, Ramachandran L, Li F, Fong CW, Kumar AP, Tan P, Sethi G.
    Clin Cancer Res; 2012 Apr 15; 18(8):2220-9. PubMed ID: 22351692
    [Abstract] [Full Text] [Related]

  • 15. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
    Algayadh IG, Dronamraju V, Sylvester PW.
    Biol Pharm Bull; 2016 Apr 15; 39(12):1974-1982. PubMed ID: 27904039
    [Abstract] [Full Text] [Related]

  • 16. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
    Parajuli P, Tiwari RV, Sylvester PW.
    Cell Prolif; 2015 Aug 15; 48(4):421-35. PubMed ID: 26096843
    [Abstract] [Full Text] [Related]

  • 17. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
    Elangovan S, Hsieh TC, Wu JM.
    Anticancer Res; 2008 Aug 15; 28(5A):2641-7. PubMed ID: 19035289
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells.
    Liu HK, Wang Q, Li Y, Sun WG, Liu JR, Yang YM, Xu WL, Sun XR, Chen BQ.
    J Nutr Biochem; 2010 Mar 15; 21(3):206-13. PubMed ID: 19195866
    [Abstract] [Full Text] [Related]

  • 19. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 15; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 20. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB, Sylvester PW.
    Biomed Pharmacother; 2010 May 15; 64(5):327-32. PubMed ID: 19954924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.